Breast carcinoma in Uganda: Microscopic study and receptor profile of 45 cases

Archives of Pathology and Laboratory Medicine

Volumn 135, Issue 2, 2011, Pages 194-199

  Roy, Indrojit ^a,c   Othieno, Emmanuel ^b  

^a MCGILL UNIVERSITY   (Canada)

^b MAKERERE UNIVERSITY   (Uganda)

^c ST MARY S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; TUMOR MARKER;

ADULT; AGE; BIOSYNTHESIS; BREAST TUMOR; CONFERENCE PAPER; FEMALE; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; MIDDLE AGED; ONSET AGE; PAGET NIPPLE DISEASE; PATHOLOGY; UGANDA;

ADULT; AGE FACTORS; AGE OF ONSET; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TUMOR MARKERS, BIOLOGICAL; UGANDA;

EID: 79952046776     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (29)

1. Gebremedhin A, Shamebo M. Clinical profile of Ethiopian patients with breast cancer. East Afr Med J. 1998; 75: 640-643.
2. Adesunkanmi ARK, Lawal OO, Adelusola KA, Durosimi MA. The severity, outcome and challenges of breast cancer in Nigeria. Breast. 2006; 15: 399-409.
3. Anderson BO, Khalil el SA. Breast conservation without mammography?: oncology practice in the real world of limited resource countries. Breast. 2006; 15: 575-579.
4. Anderson BO, Carlson RW. Guidelines for improving breast health care in limited resource countries: the Breast Health Global Initiative. J Natl Compr Canc Netw. 2007; 5(3): 349-356.
5. Anderson BO, Shyyan R, Eniu A, et al. Breast cancer in limited resource countries: an overview of the Breast Health Global Initiative 2005 Guidelines. Breast J. 2006; 12(suppl 1): S3-S15.
6. Wabinga HR, Parkin DM, Wabwire-Mangen F, Mugerwa JW. Cancer in Kampala, Uganda, in 1989-91: changes in incidence in the era of AIDS. Int J Cancer. 1993; 54(1): 26-36.
7. Gakwaya AM, Baguma P, Kigula-Mugambe JB, et al. The Uganda Breast Cancer Working Group: breast cancer guidelines for Uganda. Afr Health Sci. 2003; 3: 47-50.
8. Wolff AC, Hammond ME, Schwartz JN, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor 2 testing in breast cancer. J Clin Oncol. 2007; 25: 118-145.
9. Joslyn SA, West MM. Racial differences in breast carcinoma survival. Cancer. 2000; 88: 114-123.
10. Muthuphei MN. Carcinoma of the breast at Ga-Rankuwa Hospital histopathology laboratory (South Africa). Cent Afr J Med. 1994; 40: 254-257.
11. Bjerregaard B, Kung'u A. Breast cancer in Kenya: a histopathologic and epidemiologic study. East Afr Med J. 1992; 69: 22-26.
12. Awadelkarim KD, Arizzi C, Elamin EO, et al. Pathological, clinical and prognostic characteristics of breast cancer in Central Sudan versus Northern Italy: implications for breast cancer in Africa. Histopathology. 2008; 52: 445-456.
13. Stark A, Kapke A, Schultz D, et al. Advanced stages and poorly differentiated grade are associated with an increased risk of HER2/neu positive breast cancer only in white women: findings from a prospective cohort study of AfricanAmerican and white-American women. Breast Cancer Res Treat. 2008; 107: 405-414.
14. Amir H, Kitinya JN, Parkin DM. A comparative study of carcinoma of the breast in an African population. East Afr Med J. 1994; 71: 215-218.
15. Amir H, Azizi MR, Makwaya CK, et al. TNM classification and breast cancer in an African population: a descriptive study. Cent Afr J Med. 1997; 43: 357-359.
16. Morris GJ, Naidu S, Topham AK, et al. Differences in breast carcinoma characteristics in newly diagnosed African-American and Caucasian patients. Cancer. 2007; 110: 876-884.
17. Ihemelandu CU, Leffall LD, Dewitty RL, et al. Molecular breast cancer subtypes in premenopausal and postmenopausal African-American women: agespecific prevalence and survival. J Surg Res. 2007; 143: 109-118.
18. Rakha EA, El-Sayed ME, Lee AHS, et al. Prognostic significance of Nottingham histologic grade in invasive breast carcinoma. J Clin Oncol. 2008; 26: 3153-3158.
19. Fregene A, Newman LA. Breast cancer in sub-Saharan Africa: how does it relate to breast cancer in African-American women? Cancer. 2005; 103: 1540-1550.
20. Othieno-Abinya NA, Nyabola LO, Abwao HO, et al. Post-surgical management of patients with breast cancer at Kenyatta National hospital. East Afr Med J. 2002; 79: 156-162.
21. Ikpatt OF, Xu J, Kramtsov A, et al. Hormone receptor negative and basallike subtypes are overrepresented in invasive breast carcinoma from women of African ancestry. Proc Am Assoc Cancer Res. 2005; 46: abstract 2550.
22. Haffty BG, Yang Q, Reiss M, et al. Locoregional relapse and distant metastasis in conservatively managed triple negative early stage breast cancer. J Clin Oncol. 2006; 24: 5652-5657.
23. Diaz LK, Cryns VL, Symmans WF, et al. Triple negative breast carcinoma and the basal phenotype: from expression profiling to clinical practice. Adv Anat Pathol. 2007; 14: 419-430.
24. Nalwoga H, Arnes JB, Wabinga H, et al. Frequency of the basal-like phenotype in African breast cancer. APMIS. 2007; 115: 1391-1399.
25. Gukes ID, Jennings BA, Mandong BM, et al. Clinicopathological features and molecular markers of breast carcinoma in Jos, Nigeria. West Afr J Med. 2005; 24: 209-213.
26. Fackenthal JD. Complete allelic analysis of BRCA1 and BRCA2 variants in young Nigerian breast cancer patients. J Med Genet. 2005; 42: 276-281.
27. Paredes J, Lopes N, Milanezi F, et al. P-cadherin and cytokeratin 5: useful adjunct markers to distinguish basal-like ductal carcinoma in situ. Virchows Arch. 2007; 450: 73-80.
28. Liedkte C, Mazouni C, Hess KR, et al. Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer. J Clin Oncol. 2008; 26: 1275-1281.
29. Shyyan R, Masood S, Badwe RA, et al. Breast cancer in limited-resource countries: diagnosis and pathology. Breast J. 2006; 12: S27-S37.